National key research and development projects, 'styrene thermoplastic elastomer medical polymer raw materials research and development and industrialization' project will be held.
As a member of the project, Baling Petrochemical and Shandong Weigao Group jointly develop the project, which is also a concrete action for the strategic cooperation between Wei Gao Group, the leading enterprise and innovation leader of Sinopec, Baling Petrochemical and domestic medical device industry.
In June of this year, the Ministry of Science and Technology publicized the key national R & D project of 2017 and the research and development and industrialization of styrenic thermoplastic elastomer and polycaprolactone medical polymer materials declared by Shandong Weigao Group into the national key research and development projects Medical materials R & D and replacement of organs and organs' special focus, access to central government approval funds 17.65 million yuan. The project developed medical thermoplastic rubber SEBS (styrene / ethylene - butylene / styrene block copolymer) material, to speed up the realization The localization process of medical infusion equipment has a great social effect on the health and happiness of all people.
At present, Baling Petrochemical Thermoplastic Rubber SBS, SEBS, SIS, SEPS, SSBR and other products with a total annual output of 330,000 tons, the annual output of 30% of total domestic output, the scale of Asia in the first, the world's second, the best domestic product quality , The most complete variety of brands in China, integrated technology in the world's advanced level.
Baling Petrochemical has been working with Weigao Group to launch medical SEBS research and development since 2010. This project was included in the "Ten Dragons" scientific and technological project of Sinopec Corp. in 2016. With the joint efforts of both parties over the years, in the first half of 2016, the medical SEBS has entered the industrialized batch In the production phase, the foreign monopoly has been successfully broken and the industrialization of the project has achieved good social benefits while obtaining good economic benefits, making a positive contribution to promoting the greenization of domestic medical materials and lowering the medical costs.
In April 2016, Sinopec and Weigao Group signed a strategic cooperation agreement. Both parties will explicitly focus on the strategic planning of high-end and high-quality medical consumables in China and jointly develop new high-value-added and high-performance medical materials to achieve high-end and high-quality In August of the same year, Baling Petrochemical further signed a cooperation agreement with Viagra Group, and the cooperation between the two sides took a new step and entered the expressway.
It is reported that the state's key R & D plan is aimed at major social welfare matters related to the national economy and the people's livelihood, as well as strategic, fundamental and forward-looking major scientific issues that concern the industry's core competitiveness, overall independent innovation capability and national security, major common key technologies And products for the national economy and social development in the main areas to provide sustained support and lead.